Showing results (141-150 of 331) with videos related to
Sort By:
Pageof 34
Lupus|October 9, 2024
JAK inhibitors in systemic lupus erythematosus: Translating pathogenesis into therapyGabriela Ceobanu, Christopher J EdwardsRheumatology (Oxford, England)|April 12, 2026
Novel glucocorticoids: current status and challengesFrank Buttgereit, Christopher J EdwardsAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 18, 2021
Methods used to attribute costs avoided from pharmacist interventions in acute care: A scoping reviewSujita W Narayan, Ivo Abraham, Brian L Erstad, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 19, 2021
Proposed guidance on cost-avoidance studies in pharmacy practiceAsad E Patanwala, Sujita W Narayan, Curtis E Haas, et al.BMC Blood Disorders|October 6, 2007
Impact of delayed initiation of erythropoietin in critically ill patientsJeremiah J Duby, Brian L Erstad, Jacob Abarca, et al.Pharmacotherapy|February 1, 2011
Interdisciplinary patient care in the intensive care unit: focus on the pharmacistBrian L Erstad, Curtis E Haas, Terence O'Keeffe, et al.Arthritis Research|May 16, 2002
Statins as modulators of bone formationChristopher J Edwards, Tim D SpectorTherapeutic Advances in Musculoskeletal Disease|August 2, 2012
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityJonathan L Marks, Christopher J EdwardsJournal of Critical Care|July 1, 2014
Cost savings with interventions to reduce aerosolized bronchodilator use in mechanically ventilated patientsJames M Camamo, Kurt Weibel, Terence O'Keeffe, et al.Diabetes Research and Clinical Practice|October 23, 2015
Higher insulin infusion rate but not 24-h insulin consumption is associated with hypoglycemia in critically ill patientsJohn J Radosevich, Asad E Patanwala, Paul D Frey, et al.Pageof 34